- Conditions
- Myocardial Infarction, Cardiovascular Death, Atherothrombosis, Stroke
- Interventions
- Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 50 Years to 130 Years
- Enrollment
- 21,379 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2014
- U.S. locations
- 250
- States / cities
- Alexander City, Alabama • Athens, Alabama • Birmingham, Alabama + 247 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Coronary Heart Disease (CHD)
- Interventions
- MEDI6570, Placebo
- Biological
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 423 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 19
- States / cities
- Mobile, Alabama • Beverly Hills, California • Covina, California + 15 more
- Conditions
- Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction
- Interventions
- MyoCell™ Autologous Myoblasts
- Drug
- Lead sponsor
- Bioheart, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 5
- States / cities
- Fort Lauderdale, Florida • Atlanta, Georgia • Chicago, Illinois + 2 more
- Conditions
- Coronary Heart Disease (CHD)
- Interventions
- Evolocumab, Placebo
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 50 Years to 79 Years
- Enrollment
- 12,301 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 145
- States / cities
- Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 127 more
- Conditions
- Type 2 Diabetes Mellitus, Obesity
- Interventions
- Roux-en-Y Gastric Bypass Surgery, Laparoscopic Adjustable Gastric Banding, Lifestyle Weight Loss Intervention
- Procedure · Behavioral
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 25 Years to 55 Years
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2028
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Myocardial Infarction, Myocardial Infarction, Acute, Myocardial Infarction Old
- Interventions
- BioMonitor
- Device
- Lead sponsor
- Biotronik SE & Co. KG
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 802 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 8
- States / cities
- St Louis, Missouri • Rochester, New York • Grand Forks, North Dakota + 4 more
- Conditions
- Myocardial Infarction
- Interventions
- Prasugrel, Vorapaxar, Aspirin, Ticagrelor
- Drug
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease, Myocardial Infarct, Atherosclerotic Coronary Vascular Disease
- Interventions
- Orticumab, Placebo
- Drug
- Lead sponsor
- Abcentra
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Torrance, California • Boca Raton, Florida + 4 more